“We need the CCPA to remind us that our dreams of a decent, egalitarian society are reasonable — indeed that with a little work, they are practical. And I love that practicality, that protection of the dream of the possible.”
— Naomi Klein
Parliament’s Standing Committee on Health has identified many important and disturbing issues related to prescription drugs in Canada, including the rising costs, the review and control of prices, the approval of new drugs, the monitoring of adverse effects and prescribing practices, the marketing to and lobbying of physicians and other dispensers, direct-to-consumer advertising, the access to drugs, and the misuse, abuse and addiction within the general population.